Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06112938 · ClinicalTrials.gov registry record
Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia
A clinical trial of Stenotrophomonas Maltophilia Infection, sponsored by Methodist Health System.
- Completed
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT06112938: Completed study of Stenotrophomonas Maltophilia Infection, sponsored by Methodist Health System.
NCT06112938 is a study of Stenotrophomonas Maltophilia Infection that has completed, run by Methodist Health System. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06112938, a study of Stenotrophomonas Maltophilia Infection, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concentration (MIC) data will be interpreted per Clinical \& Laboratory Standards Institute (CLSI) standards to determine local patterns of resistance. Multivariable logistic regression will be performed to determine predictors of mortality for S. maltophilia isolates.
Primary Outcome
defined as meeting any of the following criteria: 1) isolation of S. maltophilia from a subsequently collected culture from the same site of index culture after at least 48 hours of therapy; 2) alteration of monotherapy after at least 48 hours of treatment for either an adverse event or concern for clinical failure; or 3) 30-day in-hospital all-cause mortality.
Conditions Studied
Interventions
- DRUG Antibiotic
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2025-07-14 |
What the finished NCT06112938 record still lists
NCT06112938 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Stenotrophomonas Maltophilia Infection appearing as the primary indexed condition, and to 1 intervention - of which Antibiotic is the first listed.
NCT06112938 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06112938 about?
NCT06112938 is a clinical study titled "Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia". Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concen...
What is the current status of trial NCT06112938?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2022-07-21. Estimated completion is 2025-07-14.
What conditions does trial NCT06112938 study?
This clinical trial studies the following conditions: Stenotrophomonas Maltophilia Infection.
What interventions are being tested in trial NCT06112938?
The interventions under investigation include: Antibiotic (DRUG).
Who is sponsoring clinical trial NCT06112938?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06112938 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI